Generex acquires Pantheon Medical Foot & Ankle — 3 insights

Written by Alan Condon | July 11, 2019 | Print  |

Generex Biotechnology acquired Pantheon Medical — Foot & Ankle, which develops specialty orthopedic surgery devices.

Three insights:

1. Generex will secure all assets of Pantheon including business operations, accounts receivable, inventory, contracts and real estate, among others.

2. The deal also states that the assets will be acquired on a debt free basis and in a non-cash transaction, as well as additional cash and stock consideration if sales and profit goals are met.

3. Pantheon will develop new products for submission to the FDA, which include cannulated surgical screws, surgical staples and its Hammertoe System.

"Our standard 'all-in-one' kits provide surgeons with an integrated kit of the implants, plates, screws and clips to perform 80 percent of their surgeries, and the kits can be customized for physician preference," said Travis Bird, CEO of Pantheon. "We look forward to bringing our FDA-cleared line of surgical products to the network."

More articles on devices:
Dr. Ben Walthall, former Johnson & Johnson director joins RenovaCare
Cerapedics expands Colorado HQ — 3 things to know
HSS acquires low-dose orthopedic imaging system — 3 insights



© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months